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A B S T R A C T
Vohwinkel Syndrome (VS) is a type of diffuse hereditary palmoplantar keratodermas (DHPPK)
accompanied by skeletal dimorphisms and sensorineural deafness. Themost frequently reported genetic
substrate in VS is a point mutation of GJB2 gene, responsible for encoding connexin 26, a gap-junction
protein with a crucial role in neuronal migration in rats. We report the case of a 21-year-old male who is
a second-generation member of a family with VS and developed cryptogenic focal epilepsy. Genetic
study showed a nucleotide change (c.196G > C) in exon 1 of GJB2 gene, producing a missense mutation,
D66H. It is plausible that a functional alteration of connexin 26, such as that resulting of the mutation of
our case, can produce an alteration in cortical development with epileptogenic potential. The present
case and experimental evidence that connexin 26 is related to animal epileptogenesis suggest that the
phenotypic spectrum of VS could be expanded to include epileptic manifestations.
 2009 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Diffuse hereditary palmoplantar keratodermas (DHPPK) are a
subgroup of genetically conditioned dermatological diseases with
varied modes of inheritance. Their association with systemic
clinical manifestations permits their classiﬁcation as syndromes.1
The genetic substrate is heterogeneous, but there have been
several reports of a mutation in genes that encode connexins,
transmembrane proteins with multiple biological functions.
Vohwinkel Syndrome is a DHPPK of dominant autosomal
transmission with onset at an early age. It is usually accompanied
by skeletal dimorphisms in the distal toe phalanxes and sensori-
neural deafness. Themost frequently reported genetic substrate is a
point mutation of GJB2 gene, responsible for encoding connexin 26
at locus 13q11–q12. There have also been reports of mutations of
genes that encode connexin 26 in Bart-Pumphrey Syndrome and
connexin 30 in Hydrotic Ectodermal Dysplasia.
Over the past few years, animal experiments have related
alterations in the expression of certain connexin subtypes to
epileptogenesis. Thus, functional alterations of connexins 26, 32,
36 and 43 are known to be implicated in the genesis and
synchronization of cortical electrical activity in rats.2 There is also
evidence of the importance of connexins 26 and 43 for controlling* Corresponding author at: Unidad de Neurologia y Neuroﬁsiologı´a, Hospital
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doi:10.1016/j.seizure.2009.11.009the ﬁnal stages of neuronal migration in rats.3 Finally, a human
study showed a signiﬁcantly lower expression of connexins 32, 36,
and 43 in the hippocampus of epileptic patients subjected to
therapeutic amygdalohippocampectomy versus controls (autopsy
samples from non-epileptic patients).4
Despite this accumulated knowledge of connexin proteomics,
there is no consistent evidence in the literature of an association
with epilepsy in DHPPK, only isolated cases. This may be explained
by the extreme rarity of these diseases and the little information on
their natural history.
We present a family affected by Vohwinkel disease type DHPPK
in which at least one member of the family had cryptogenic partial
epilepsy. The sequencing of GJB2 gene revealed a speciﬁcmutation.
We discuss the possible biological meaning of this association.
2. Case report
We report the case of a 21-year-old male with mild
psychomotor development retardationwho is a second-generation
member of a family with DHPPK. The mother and maternal
grandfather show dermatological but not systemic involvement.
The patient and his mother have clinically relevant sensorineural
deafness, but it is not knownwhether this was also suffered by the
maternal grandfather. There is no other history of interest.
From the age of 8 years, the patient suffered episodes that
started with a cessation of activity, expression of fear, disconnec-
tion from the environment, and a subtle oral and swallowing
automatism that lasted a few minutes. These episodes were
considered compatible with complex partial seizures in the
context of focal cryptogenic epilepsy. The only semiological datavier Ltd. All rights reserved.
Fig. 1. EEG showing bifrontal epileptiform activity with left predominance.
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consistently related with temporal lobe origin. Nevertheless,
interictal electroencephalograms showed bifrontal epileptiform
activity with left predominance (Fig. 1), suggesting a possible
frontal onset with rapid extension to fronto-temporal areas.
They occasionally culminated in generalized seizures. There is
not a predominance of seizures during sleep and postictal period
was always of short duration.
The frequency of seizures until 16 years old was about 1–2
seizures per week, but since this moment and coinciding with the
start of the combination therapy with Carbamazepine plus
Lamotrigine, the patient became free of seizures. Previously there
had been several therapeutic trials inmonotherapy or combination
of AED including Phenobarbital, Fenitoine and Valproic Acid.
The basic neurological examination was normal. High-resolu-
tion encephalic MRI (1.5 T) with a speciﬁc epilepsy protocol found
no relevant alterations.
Directed genetic study revealed a nucleotide change
(c.196G > C) in exon 1 of GJB2 gene in heterozygosis, producing
a missense mutation, D66H. This mutation involves the exchange
of an aspartic aminoacid for a histidine codon in codon 66 and has
been frequently reported in Vohwinkel Syndrome.5 The same
mutation was found in a sample from his mother, who has
dermatological lesions but no reported epileptic seizures.
3. Discussion
Connexins are transmembrane proteins involved in intercellu-
lar communication processes.6 In general, they permit cell
metabolite exchange, second messengers, and electrical signals.
There are 21 members of the connexin family in humans, with a
widely heterogeneous distribution in different organs. There was
initially believed to be a speciﬁc connexin for each cell type, but
many tissues are now known to express two or more members of
this family. Thus, keratocytes express connexins 26, 30, 30.3, 31,
31.1, and 43; cardiomyocytes, 40, 43, and 45; and hepatocytes, 26
and 32. Hence, a mutation in a speciﬁc connexin can produce
alterations in various tissues.Various authors recently suggested that the expression of
certain subtypes of neuronal connexins may be altered in some
types of epilepsy. Thus, Hempelmann et al. found evidence of an
allelic and genotypic association between the connexin 36 gene
and a subtype of patients with juvenile myoclonic epilepsy.7
However, to our best knowledge, connexin 26 has yet to be related
to any type of epilepsy.
Our patient presents an unusual phenotype, with pharmaco-
sensitive cryptogenic partial epilepsy and palmoplantar kerato-
derma, with a mutation of exon 1 in the gene encoding connexin
26. This genetic substrate was described in a large British family
with conventional Vohwinkel Syndrome, which had 10 members
with this mutation, and it was subsequently detected in three non-
related families of Spanish and Italian origin.5 These patients
suffered moderate-to-severe sensorineural hypoacusia but there
were no reports of epileptic seizures. The authors suggested that
this speciﬁc mutation of connexin 26 may affect epidermal
differentiation and inner ear function. Other families have since
been reported to have the same mutation and a classic phenotype
of the Vohwinkel Syndrome.8
Connexin 26 has been experimentally demonstrated to
participate in epidermal differentiation.9 In 2007, it was reported
to play a crucial role in neuronal migration in rats,3 with the
expression of connexins 26 and 43 in contact points between radial
ﬁbers and neurons during neuron migration, and a decrease in
their expression was found to affect the cortical organization
process. The authors also demonstrated that connexins guide
neuronal migration in a novel manner, developing dynamic
adhesive contacts that interact with the neuronal cytoskeleton
and stabilize it along the radial ﬁbers.
Based on the experimental evidence, it is plausible that a
functional alteration of connexin 26, such as that resulting from
D66Hmutation of exon 1 in GJB2 gene, can produce an alteration in
epidermal differentiation, responsible for keratoderma, and a
simultaneous alteration in cortical development, with epilepto-
genic potential. This alteration would probably take place in the
last stages of cortical development and may therefore not be
detected in standard neuroimaging studies.
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keywords ‘‘keratoderma’’ and ‘‘epilepsy’’, revealed a previous case
of Vohwinkel Syndrome associated with a partial complex seizure,
but the genetic substrate was not reported.10
In conclusion, D66H mutation of exon 1 in GJB2 gene may
produce a multisystemic syndrome with palmoplantar kerato-
derma and sensorineural hypoacusia. The present ﬁndings and
experimental evidence that connexin 26 is related to animal
epileptogenesis and cortical organization suggest that this
phenotypic spectrum can be expanded to include manifestations
of cryptogenic focal epilepsy. Possible mutations of GJB2 gene
should be investigated in patients with cryptogenic focal epilepsy
with associated palmoplantar keratodermal lesions and/or familial
sensorineural deafness.
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